Search For "active pharmaceutical ingredients"
Academic research scholar Dr Kannan Vishwanatth was conferred Honorary Pro
Updated : 3 years, 11 months ago IST
California [US], April 16 (Newsvoir/ANI): (Prof) Dr Kannan Vishwanatth, noted academic researcher & Founder & Managing Director of Hong Kong based Rupus Global Limited, a globally acclaimed research-focused vertically integrated pharmaceutical Company, which contract manufactures act
Read More
Local manufacturing of 35 APIs in 32 plants starts under PLI scheme: Mansu
Updated : 3 years, 11 months ago IST
New Delhi [India], March 29 (ANI): The manufacturing of 35 active pharmaceutical ingredients (APIs), which have been imported earlier, started in India under the production linked scheme, said Union Health Minister Mansukh Mandaviya on Tuesday.
Read More
Supriya Lifescience makes stock market debut at 55 per cent premium
Updated : 4 years, 2 months ago IST
Mumbai [India], December 28 (ANI): Supriya Lifescience, an active pharmaceutical ingredients manufacturer, made a strong debut at the stock market on Tuesday with its share getting listed at 55 per cent premium over its issue price of Rs.274 per share.
Read More
Jubilant Pharma ratings unaffected by proposed reorganisation: Fitch
Updated : 4 years, 7 months ago IST
Mumbai (Maharashtra) [India], July 30 (ANI): The proposed transfer of Jubilant Pharma Ltd's (JPL's) active pharmaceutical ingredients (API) business to its parent Jubilant Pharmova Ltd (JPHL) will not affect JPL's ratings, says Fitch Ratings.
Read More
Govt waives import duty on Remdesivir API, injections and specific inputs
Updated : 4 years, 10 months ago IST
New Delhi [India], April 21 (ANI): The import of Remdesivir Active Pharmaceutical Ingredients (API), injections and specific inputs have been made import duty free till October 31 amid the ongoing surge in COVID-19 cases in the country.
Read More
Centre prohibits exports of Remdesivir till COVID-19 situation in India im
Updated : 4 years, 11 months ago IST
New Delhi [India]. April 11 (ANI): The Centre on Sunday prohibited exports of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the Covid-19 situation in the country improves.
Read More
Morepen labs eyeing multi-billion dollar global market for New API molecul
Updated : 5 years, 1 month ago IST
New Delhi [India], February 12 (ANI/NewsVoir): Morepen Laboratories Ltd. is eyeing an all-new multi-billion dollar global API (Active Pharmaceutical Ingredients) market with the addition of new molecules in its bulk drugs portfolio. The focus areas of these new molecules include chronic and
Read More
India's incentives for domestic API production could cut supply risk: Fitc
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 10 (ANI): The Indian government's recent incentives to boost domestic manufacturing of active pharmaceutical ingredients (APIs) and key starting materials (KSMs) can improve backward integration over the next few years and curtail supply-chain disruption ris
Read More
Indian pharma compliance standards improving, regulatory risks here to sta
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 7 (ANI): Indian pharmaceutical companies have built a strong abbreviated new drug application (ANDA) pipeline since FY12 through scaling-up of investments in R&D but this will increase the inspection intensity, India Ratings and Research (Ind-Ra) said o
Read More
Centre removes restrictions on exports of paracetamol APIs
Updated : 5 years, 9 months ago IST
New Delhi [India], May 29 (ANI): The Central government on Thursday removed restrictions on the export of paracetamol APIs (active pharmaceutical ingredients) making it export free.
Read More
Govt removes export restrictions on 12 APIs
Updated : 5 years, 11 months ago IST
New Delhi [India], April 7 (ANI): The Central government has removed restrictions on the export of 12 Active Pharmaceutical Ingredients (APIs) and their formulations, the Union Commerce and Industry Ministry said on Monday.
Read More
Coronavirus: No shortage of APIs, formulations, says NPPA
Updated : 6 years ago IST
New Delhi [India], Mar 14 (ANI): The National Pharmaceutical Pricing Authority (NPPA) on Friday said that they have not received any reference regarding the shortage of active pharmaceutical ingredients (APIs) and formulations.
Read More